| 000 | 01067 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518075317.0 | ||
| 264 | 0 | _c20200410 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1097-4598 | ||
| 024 | 7 |
_a10.1002/mus.26787 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLandfeldt, Erik | |
| 245 | 0 | 0 |
_aImprovements in health status and utility associated with ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy. _h[electronic resource] |
| 260 |
_bMuscle & nerve _c03 2020 |
||
| 300 |
_a363-368 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCodon, Nonsense |
| 650 | 0 | 4 | _aDelphi Technique |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 650 | 0 | 4 |
_aOxadiazoles _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLindberg, Christopher | |
| 700 | 1 | _aSejersen, Thomas | |
| 773 | 0 |
_tMuscle & nerve _gvol. 61 _gno. 3 _gp. 363-368 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mus.26787 _zAvailable from publisher's website |
| 999 |
_c30458521 _d30458521 |
||